Literature DB >> 4297690

Studies of adenovirus type 3 infection treated with methisazone and trifluorothymidine.

J M Little, D W Lorenzetti, D C Brown, H H Schweem, B R Jones, H E Kaufman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4297690     DOI： 10.3181/00379727-127-32862

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  7 in total

1.  Topical human fibroblast interferon for acute adenoviral conjunctivitis.

Authors:  K R Wilhelmus; E C Dunkel; J Herson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

Review 2.  Epidemic keratoconjunctivitis: the current situation and recommendations for prevention and treatment.

Authors:  Birthe Meyer-Rüsenberg; Ulrike Loderstädt; Gisbert Richard; Paul-Michael Kaulfers; Caroline Gesser
Journal:  Dtsch Arztebl Int       Date:  2011-07-08       Impact factor: 5.594

3.  Comparison of clinical outcome with different treatment regimens in acute adenoviral keratoconjunctivitis.

Authors:  L Asena; E Şıngar Özdemir; A Burcu; E Ercan; M Çolak; D D Altınörs
Journal:  Eye (Lond)       Date:  2017-02-03       Impact factor: 3.775

Review 4.  Infectious diseases. Annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1969-07       Impact factor: 2.401

5.  Small molecules enhance CRISPR genome editing in pluripotent stem cells.

Authors:  Chen Yu; Yanxia Liu; Tianhua Ma; Kai Liu; Shaohua Xu; Yu Zhang; Honglei Liu; Marie La Russa; Min Xie; Sheng Ding; Lei S Qi
Journal:  Cell Stem Cell       Date:  2015-02-05       Impact factor: 24.633

Review 6.  Trifluridine: a review of its antiviral activity and therapeutic use in the topical treatment of viral eye infections.

Authors:  A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-05       Impact factor: 9.546

7.  Cyclosporine a 0.05% eye drops for the treatment of subepithelial infiltrates after epidemic keratoconjunctivitis.

Authors:  Seydi Okumus; Erol Coskun; Mehmet Gurkan Tatar; Erdal Kaydu; Ramazan Yayuspayi; Aysegul Comez; Ibrahim Erbagci; Bulent Gurler
Journal:  BMC Ophthalmol       Date:  2012-08-18       Impact factor: 2.209
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.